Akaunting up to 3.1.21 Invoice/Billing notes cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.2 | $0-$5k | 1.04 |
Summary
A vulnerability was found in Akaunting up to 3.1.21 and classified as problematic. Impacted is an unknown function of the component Invoice/Billing. The manipulation of the argument notes results in cross site scripting. This vulnerability was named CVE-2026-5568. The attack may be performed from remote. In addition, an exploit is available. The vendor was contacted early about this disclosure but did not respond in any way.
Details
A vulnerability classified as problematic has been found in Akaunting up to 3.1.21. Affected is an unknown code of the component Invoice/Billing. The manipulation of the argument notes with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity.
The advisory is available at docs.google.com. This vulnerability is traded as CVE-2026-5568. The exploitability is told to be easy. It is possible to launch the attack remotely. Successful exploitation requires user interaction by the victim. Technical details and a public exploit are known. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
The exploit is shared for download at docs.google.com. It is declared as proof-of-concept. The vendor was contacted early about this disclosure but did not respond in any way.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2026-19083). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Name
Version
- 3.1.0
- 3.1.1
- 3.1.2
- 3.1.3
- 3.1.4
- 3.1.5
- 3.1.6
- 3.1.7
- 3.1.8
- 3.1.9
- 3.1.10
- 3.1.11
- 3.1.12
- 3.1.13
- 3.1.14
- 3.1.15
- 3.1.16
- 3.1.17
- 3.1.18
- 3.1.19
- 3.1.20
- 3.1.21
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.5VulDB Meta Temp Score: 3.2
VulDB Base Score: 3.5
VulDB Temp Score: 3.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
04/04/2026 Advisory disclosed04/04/2026 VulDB entry created
04/06/2026 VulDB entry last update
Sources
Advisory: docs.google.comStatus: Not defined
CVE: CVE-2026-5568 (🔒)
GCVE (CVE): GCVE-0-2026-5568
GCVE (VulDB): GCVE-100-355338
EUVD: 🔒
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 04/04/2026 16:34Updated: 04/06/2026 00:08
Changes: 04/04/2026 16:34 (55), 04/06/2026 00:08 (1)
Complete: 🔍
Submitter: gabriel
Cache ID: 216:7FE:103
Submit
Accepted
- Submit #783139: Akaunting v3.1.21 Cross Site Scripting (by gabriel)
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.